Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan

被引:11
作者
Chuang, Li-Chung [1 ,2 ]
Chen, Hui-Chi [1 ,3 ]
You, San-Lin [1 ]
Lin, Ching-Yu [4 ]
Pan, Mei-Hung [1 ]
Chou, Yi-Chun [3 ]
Hsieh, Chang-Yao [5 ]
Chen, Chien-Jen [1 ,3 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan
[2] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan
[3] Natl Taiwan Univ, Grad Inst Epidemiol, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 110, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Obstet & Gynaecol, Taipei 100, Taiwan
关键词
Human papillomavirus; Adenocarcinoma; Rectum; POLYMERASE-CHAIN-REACTION; COLORECTAL-CANCER; CERVICAL-CANCER; ANAL CANCER; INFECTION; HPV; COLON; RISK; DNA; SURVIVORS;
D O I
10.1007/s10552-010-9631-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed at assessing the association between the type-specific human papillomavirus (HPV) infection and the risk of adenocarcinoma of the rectum and recto-sigmoid junction. A total of 10,612 women aged 30-65 years old were enrolled from seven townships in Taiwan. Cervical cells collected at study entry were tested for 39 types of HPV infection by polymerase chain reactions and HPV blot kit. Newly developed adenocarcinomas of rectum and recto-sigmoid junction were ascertained through computerized linkage with national cancer registry profiles. An increased risk of adenocarcinomas of the rectum and recto-sigmoid junction was observed with HPV infection, showing a hazard ratio [HR] (95% confidence interval [CI]) of 1.99 (0.98-4.04) after adjustment for age and body mass index. The adjusted HR (95% CI) for the infection of HPV types other than 6 and 11 was 2.18 (1.04-4.60). Women with cervical infection of HPV types other than 6 and 11 at study entry may have an increased risk of adenocarcinomas of the rectum and recto-sigmoid junction, which deserves further validation by large-scale studies.
引用
收藏
页码:2123 / 2128
页数:6
相关论文
共 28 条
[1]   Potential Role of Human Papillomavirus in the Development of Subsequent Primary In Situ and Invasive Cancers Among Cervical Cancer Survivors [J].
Balamurugan, Appathurai ;
Ahmed, Faruque ;
Saraiya, Mona ;
Kosary, Carol ;
Schwenn, Molly ;
Cokkinides, Vilma ;
Flowers, Lisa ;
Pollack, Lori A. .
CANCER, 2008, 113 (10) :2919-2925
[2]   Controlling the false discovery rate in behavior genetics research [J].
Benjamini, Y ;
Drai, D ;
Elmer, G ;
Kafkafi, N ;
Golani, I .
BEHAVIOURAL BRAIN RESEARCH, 2001, 125 (1-2) :279-284
[3]   MULTIPLE SIGNIFICANCE TESTS - THE BONFERRONI METHOD .10. [J].
BLAND, JM ;
ALTMAN, DG .
BRITISH MEDICAL JOURNAL, 1995, 310 (6973) :170-170
[4]   Colorectal papillomavirus infection in patients with colorectal cancer [J].
Bodaghi, S ;
Yamanegi, K ;
Xiao, SY ;
Da Costa, M ;
Palefsky, JM ;
Zheng, ZM .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2862-2867
[5]   A review of human carcinogens-Part B: biological agents [J].
Bouvard, Veronique ;
Baan, Robert ;
Straif, Kurt ;
Grosse, Yann ;
Secretan, Beatrice ;
El Ghissassi, Fatiha ;
Benbrahim-Tallaa, Lamia ;
Guha, Neela ;
Freeman, Crystal ;
Galichet, Laurent ;
Cogliano, Vincent .
LANCET ONCOLOGY, 2009, 10 (04) :321-322
[6]  
BURKITT DP, 1971, CANCER, V28, P3, DOI 10.1002/1097-0142(197107)28:1<3::AID-CNCR2820280104>3.0.CO
[7]  
2-N
[8]   Second cancers among 104,760 survivors of cervical cancer:: Evaluation of long-term risk [J].
Chaturvedi, Anil K. ;
Engels, Eric A. ;
Gilbert, Ethel S. ;
Chen, Bingshu E. ;
Storm, Hans ;
Lynch, Charles F. ;
Hall, Per ;
Langmark, Froydis ;
Pukkala, Eero ;
Kaijser, Magnus ;
Andersson, Michael ;
Fossa, Sophie D. ;
Joensuu, Heikki ;
Boice, John D. ;
Kleinerman, Ruth A. ;
Travis, Lois B. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (21) :1634-1643
[9]   Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer [J].
Daling, JR ;
Madeleine, MM ;
Johnson, LG ;
Schwartz, SM ;
Shera, KA ;
Wurscher, MA ;
Carter, JJ ;
Porter, PL ;
Galloway, DA ;
McDougall, JK .
CANCER, 2004, 101 (02) :270-280
[10]  
DAMIN DC, 2007, EUR J SURG ONCOL